Author

M. Leening

h-index 37 View on Semantic Scholar

We have 3 of 132 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Lipoprotein(a) distributions and trial eligibility thresholds for Lp(a)-lowering therapies in the general population: The Rotterdam Study.

AIMS General population distributions of lipoprotein(a) (Lp(a)) are well-characterized. However, less is known about its distributions and associated event rates within high-risk populations, including individuals with atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD) and varying levels of su...

Gaia Hermans, D. Bos, M. Kavousi et al. · European Journal of Preventi... · 0 citations

Review Open access Sep 2026

Obesity, incretin-based therapies, and cardiovascular disease in women

This review addresses the need for a life course and sex-specific approach to obesity and its treatment, integrating metabolic, reproductive, and cardiovascular perspectives.

Miro Salih, Yannicke A. J. Sloots, M. Hemels et al. · Netherlands Heart Journal · 0 citations

#federated learning Jul 2026

Federated Deep Learning for Privacy-Preserving Cardiovascular Disease Risk Prediction

It is suggested that federated deep learning across heterogeneous cohorts can improve cardiovascular disease risk prediction while preserving the privacy of individual-level patient data.

Hyunho Mo, Djura Smits, Mahlet A. Birhanu et al. · arXiv.org · 0 citations